FindTrial
Sign In

The link between iron, inflammation, and small blood vessel damage in type 2 diabetes

Correlation of serum ferritin, and highly sensitive c reactive protein with microvascular complications in cases of type ii diabetes mellitus - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/03/105332
Enrollment
156
Registered
2026-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: Nil: Nil

Sponsors

Datta meghe institute of higher education and research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Diagnosed T2DM (per ADA guidelines). 2 Age between 18 to 70 years. 2 Informed consent provided.

Exclusion criteria

Exclusion criteria: 1 Acute infections, chronic inflammatory conditions. 2 Known iron metabolism disorders or iron supplementation. 3 Chronic liver disease, malignancies, or hematological disorders. 4 Type 1 or gestational diabetes. 5 Recent surgeries or trauma (within last 3 months).

Design outcomes

Primary

MeasureTime frame
Serum ferritin and highly sensitive c reactive protein can be used as prognostic marker for microvascular complications in cases of type ii diabetes mellitusTimepoint: at baseline, after completion of trial—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Anuj Varma

Datta meghe institute of higher education and research

anujvarma1985@gmail,com9860500065

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026